Please Wait.....
Report
Middle East & Africa Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
Market Report I 2023-10-26 I 128 Pages I The Insight Partners
The Middle East & Africa clinical trials market is expected to grow from US$ 1,524.94 million in 2022 to US$ 1,923.39 million by 2028. It is estimated to grow at a CAGR of 3.9% from 2022 to 2028.
Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials Fuels Middle East & Africa clinical trials market.
In decentralized clinical trials (DCT), patients' physical access to hospital-based trial sites is reduced or eliminated. In DCTs, digital technologies are used to enable access of patients to clinical research, remote data collection and monitoring, and communication between investigators and participants. A hybrid clinical trial approach combines home-based and on-site activities, bringing the best patient experience and meeting complex protocol regimes, gaining traction across various therapeutic areas and trial phase journeys. Initially, due to challenges such as patient privacy, data security, regulatory barriers, and complex protocol regimes, the adoption of DCT was affected. However, due to the COVID-19 pandemic, the sponsors of clinical trials adopted decentralized and hybrid clinical techniques for developing drugs. They could not continue with traditional trials as they required in-person visits. Due to the restrictions for travel, the only way to gather data and keep trials going was to work remotely and adopt technology much faster than they would have otherwise. Therefore, decentralization broadens trial access to reach a larger number and potentially a more diverse pool of patients.
Further, hybrid clinical trials allow sponsors to strategically incorporate decentralized clinical trial (DCT) elements into study designs. These trial models offer unprecedented flexibility, so more companies are interested in hybrid trials, and the resulting growth is redefining the industry landscape. According to ObvioHealth, the FDA plans to unveil protocols in 2023 to support the use of DCT methods, inspiring confidence in these components for future clinical research. Thus, the increasing focus on using decentralized and hybrid clinical trials over traditional clinical trial methods is expected to provide lucrative opportunities for the clinical trials market during the forecast period.
Middle East & Africa Clinical Trials Market Overview
The clinical trials market in the Middle East & Africa is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. The regional growth is attributed to rising rate of cancer and investments in developing healthcare infrastructure. Factors such as growing awareness of the advantages of clinical trials, government showing a propensity to spend on healthcare infrastructure and research are likely to further propel the clinical trials market growth during the forecast period.
Middle East & Africa Clinical Trials Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Clinical Trials Market Segmentation
The Middle East & Africa clinical trials market is segmented into phase, study design, indication, and country.
Based on phase, the Middle East & Africa clinical trials market is segmented into phase I, phase II, phase III, and phase IV. The phase III segment registered the largest Middle East & Africa clinical trials market share in 2022.
Based on study design, the Middle East & Africa clinical trials market is segmented into interventional, observational, and expanded access. The interventional segment held the largest Middle East & Africa clinical trials market share in 2022.
Based on indication, the Middle East & Africa clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, CNS condition, diabetes, obesity, cardiovascular, and others. The oncology segment held the largest Middle East & Africa clinical trials market share in 2022.
Based on country, the Middle East & Africa clinical trials market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa clinical trials market share in 2022.
ICON Plc; IQVIA Holdings Inc; Laboratory Corp of America Holdings; Parexel International Corp; SGS SA; Syneos Health Inc; Thermo Fisher Scientific Inc; and WuXi AppTec Co Ltd. are some of the leading companies operating in the Middle East & Africa clinical trials market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Clinical Trials Market - By Phase
1.3.2 Middle East & Africa Clinical Trials Market - By Study Design
1.3.3 Middle East & Africa Clinical Trials Market - By Indication
1.3.4 Middle East & Africa Clinical Trials Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Clinical Trials Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa PEST Analysis
4.3 Experts Opinion
5. Middle East & Africa Clinical Trials Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Adoption and Outsourcing of Clinical Trials
5.1.2 Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry
5.2 Market Restraints
5.2.1 Expensive and Time-Consuming Process
5.3 Market Opportunities
5.3.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
5.4 Future Trends
5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis
6. Clinical Trials Market - Middle East & Africa Analysis
6.1 Middle East & Africa Clinical Trials Market Revenue Forecast and Analysis
7. Middle East & Africa Clinical Trials Market Revenue and Forecast To 2028 - by Study Design
7.1 Overview
7.2 Middle East & Africa Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
7.3 Interventional
7.3.1 Overview
7.3.2 Interventional: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Observational
7.4.1 Overview
7.4.2 Observational: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Expanded Access
7.5.1 Overview
7.5.2 Expanded Access: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Clinical Trials Market - By Phase
8.1 Overview
8.2 Middle East & Africa Clinical Trials Market, by Phase, 2022 and 2028 (%)
8.3 Phase III
8.3.1 Overview
8.3.2 Phase III: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Phase II
8.4.1 Overview
8.4.2 Phase II: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Phase IV
8.5.1 Overview
8.5.2 Phase IV: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Phase I
8.6.1 Overview
8.6.2 Phase I: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Clinical Trials Market Revenue and Forecast To 2028 - Indication
9.1 Overview
9.2 Middle East & Africa Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
9.3 Autoimmune/Inflammation
9.3.1 Overview
9.3.2 Autoimmune/Inflammation: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Pain Management
9.4.1 Overview
9.4.2 Pain Management: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Oncology
9.5.1 Overview
9.5.2 Oncology: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.6 CNS Condition
9.6.1 Overview
9.6.2 CNS Condition: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Diabetes
9.7.1 Overview
9.7.2 Diabetes: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.8 Obesity
9.8.1 Overview
9.8.2 Obesity: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.9 Cardiovascular
9.9.1 Overview
9.9.2 Cardiovascular: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.10 Other
9.10.1 Overview
9.10.2 Other: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 - Country Analysis
10.1 Middle East & Africa: Clinical Trials Market
10.1.1 Overview
10.1.2 Middle East & Africa: Clinical Trials Market, by Country, 2022 & 2028 (%)
10.1.2.1 Saudi Arabia: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 Saudi Arabia: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 Saudi Arabia: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.1.4 Saudi Arabia: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.1.5 Saudi Arabia: Clinical Trials Market, by Indication 2020-2028 (US$ Million)
10.1.2.2 UAE: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 UAE: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 UAE: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.2.4 UAE: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.2.5 UAE: Clinical Trials Market, by Indication 2020-2028 (US$ Million)
10.1.2.3 South Africa: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 South Africa: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 South Africa: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.3.4 South Africa: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.3.5 South Africa: Clinical Trials Market, by Indication 2020-2028 (US$ Million)
10.1.2.4 Rest of Middle East & Africa: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Rest of Middle East & Africa: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.3 Rest of Middle East & Africa: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.4.4 Rest of Middle East & Africa: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.4.5 Rest of Middle East & Africa: Clinical Trials Market, by Indication 2020-2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 IQVIA Holdings Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Parexel International Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 ICON Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 WuXi AppTec Co Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 SGS SA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Syneos Health Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Thermo Fisher Scientific Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Laboratory Corp of America Holdings
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia Clinical Trials Market, by Study Design- Revenue and Forecast to 2028 (US$ Million)
Table 3. Saudi Arabia Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 4. UAE Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 5. UAE Clinical Trials Market, by Study Design- Revenue and Forecast to 2028 (US$ Million)
Table 6. UAE Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 7. South Africa Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 8. South Africa Clinical Trials Market, by Study Design- Revenue and Forecast to 2028 (US$ Million)
Table 9. South Africa Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 10. Rest of Middle East & Africa Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 11. Rest of Middle East & Africa Clinical Trials Market, by Study Design- Revenue and Forecast to 2028 (US$ Million)
Table 12. Rest of Middle East & Africa Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 13. Organic Developments Done by Companies
Table 14. Inorganic Developments Done by Companies
Table 15. Glossary of Terms
LIST OF FIGURES
Figure 1. Middle East & Africa Clinical Trials Market Segmentation
Figure 2. Middle East & Africa Clinical Trials Market, By Region
Figure 3. Middle East & Africa Clinical Trials Market Overview
Figure 4. Phase III Segment Held Largest Share of Phase Segment in Middle East & Africa Clinical Trials Market
Figure 5. The UAE is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Middle East and Africa: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis
Figure 9. Middle East & Africa Clinical Trials Market- Revenue Forecast and Analysis - 2020- 2028
Figure 10. Middle East & Africa Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
Figure 11. Interventional: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Observational: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Expanded Access: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Middle East & Africa Clinical Trials Market, by Phase 2022 and 2028 (%)
Figure 15. Phase III: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Phase II: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Phase IV: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Phase I: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Middle East & Africa Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
Figure 20. Autoimmune/Inflammation: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Pain Management: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Oncology: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. CNS Condition: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Diabetes: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Obesity: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiovascular: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other: Middle East & Africa Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Middle East & Africa: Clinical Trials Market, by Key Country - Revenue (2022) (US$ Million)
Figure 29. Middle East & Africa: Clinical Trials Market, by Country, 2022 & 2028 (%)
Figure 30. Saudi Arabia: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. UAE: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. South Africa: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of Middle East & Africa: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Growth Strategies Done by the Companies in the Market, (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security